| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | LADENBURG THALMAN FIN SVCS I | 111,789 | 352,135 | 0.04% | ||
| 2 | GTX INC | 265,193 | 365,966 | 0.04% | ||
| 3 | TONIX PHARMACEUTICALS HLD | 92,262 | 1,323,960 | 0.16% | ||
| 4 | METABOLIX INC RESTRICTED | 1,658,126 | 1,442,570 | 0.18% | ||
| 5 | BIOGEN INC | 7,723 | 2,435,139 | 0.30% | ||
| 6 | AGENUS INC | 1,161,134 | 3,738,855 | 0.45% | ||
| 7 | GILEAD SCIENCES INC | 50,000 | 4,145,500 | 0.50% | ||
| 8 | DERMA SCIENCES INC COM PAR .01 | 492,796 | 5,696,722 | 0.69% | ||
| 9 | AMARIN CORP PLC | 3,700,000 | 6,512,000 | 0.79% | ||
| 10 | BLUEBIRD BIO INCORPORATED | 178,937 | 6,901,600 | 0.84% | ||
| 11 | GENTIVA HEALTH SER | 601,960 | 9,065,518 | 1.10% | ||
| 12 | INTREXON CORP | 368,500 | 9,260,405 | 1.12% | ||
| 13 | BIOLASE INC | 6,135,910 | 13,499,002 | 1.64% | ||
| 14 | WebMD Health Corp | 300,141 | 14,496,810 | 1.76% | ||
| 15 | VERMILLION INC | 7,139,960 | 18,421,097 | 2.24% | ||
| 16 | PACIFIC BIOSCIENCES CALIF IN | 3,002,508 | 18,555,499 | 2.25% | ||
| 17 | TESARO INC | 633,752 | 19,716,025 | 2.39% | ||
| 18 | REPROS THERAPEUTICS INC | 1,267,126 | 21,921,280 | 2.66% | ||
| 19 | IRONWOOD PHARMACEUTICALS INC COM CL A | 1,620,905 | 24,848,474 | 3.02% | ||
| 20 | HANSEN MEDICAL INC | 19,546,539 | 25,605,966 | 3.11% | ||
| 21 | ACCURAY INCORPORATED COM | 3,616,293 | 31,823,378 | 3.86% | ||
| 22 | TRANSITION THERAPEUTICS INC | 4,851,321 | 32,600,877 | 3.96% | ||
| 23 | OPKO HEALTH INC | 5,655,738 | 49,996,724 | 6.07% | ||
| 24 | THORATEC LABS CORP | 1,466,304 | 51,115,357 | 6.20% | ||
| 25 | NXSTAGE MED INC COM | 3,723,407 | 53,505,359 | 6.49% | ||
| 26 | MAZOR ROBOTICS LTD | 3,154,281 | 55,420,717 | 6.73% | ||
| 27 | QUIDEL CORP COM | 2,915,633 | 64,464,646 | 7.82% | ||
| 28 | ACORDA THERAPEUTICS | 1,931,414 | 65,107,966 | 7.90% | ||
| 29 | TENET HEALTHCARE CORP THC | 1,518,876 | 71,296,039 | 8.65% | ||
| 30 | ACCELERATE DIAGNOSTICS INC | 5,394,058 | 140,245,508 | 17.02% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001085146-14-001776, filed 2014.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
